Skip to main content
Top
Published in: Rheumatology International 5/2013

01-05-2013 | Original Article

The co-occurrence of Hashimoto thyroiditis in primary Sjogren’s syndrome defines a subset of patients with milder clinical phenotype

Authors: Paola Caramaschi, Domenico Biasi, Cristian Caimmi, Cinzia Scambi, Sara Pieropan, Giovanni Barausse, Silvano Adami

Published in: Rheumatology International | Issue 5/2013

Login to get access

Abstract

To evaluate in a cohort of 100 consecutive patients affected by primary Sjogren’s syndrome (pSS) the incidence of Hashimoto thyroiditis (HT) and to compare the clinical features and the laboratory parameters of patients affected by pSS with and without concomitant HT. In 100 consecutive patients affected by pSS, the occurrence of other autoimmune diseases was recorded and a full examination of thyroid function obtained. HT was associated with pSS in 27 cases. The comparison between pSS cases with and without HT showed that only patients with isolated pSS had low C4 level [p = 0.032, OR (IC 95 %) 230 (13.13–4,046)]. In addition, only patients affected by pSS without HT had evidence of cryoglobulins, cutaneous vasculitis with palpable purpura, peripheral neuropathy, and development of lymphoma, although all these manifestations were observed in a 4.1–8.2 % of the cases, without reaching statistical significance. The association of HT in patients suffering from pSS defines a subset of patients with milder disease and normal C4 levels.
Literature
1.
go back to reference Zeher M, Horvath IF, Szanto A, Szodoray P (2009) Autoimmune thyroid diseases in a large group of Hungarian patients with primary Sjogren’s syndrome. Thyroid 19:39–45PubMedCrossRef Zeher M, Horvath IF, Szanto A, Szodoray P (2009) Autoimmune thyroid diseases in a large group of Hungarian patients with primary Sjogren’s syndrome. Thyroid 19:39–45PubMedCrossRef
2.
go back to reference D’Arbonneau F, Ansart S, Le Berre R, Dueymes M, Youinou P, Pennec YL (2003) Thyroid dysfunction in primary Sjogren’s syndrome: a long-term followup study. Arthr Care Res 49:804–809CrossRef D’Arbonneau F, Ansart S, Le Berre R, Dueymes M, Youinou P, Pennec YL (2003) Thyroid dysfunction in primary Sjogren’s syndrome: a long-term followup study. Arthr Care Res 49:804–809CrossRef
3.
go back to reference Horvath IF, Szodoray P, Zeher M (2008) Primary Sjogren’s syndrome in men: clinical and immunological characteristic based on a large cohort of Hungarian patients. Clin Rheumatol 27:1479–1483PubMedCrossRef Horvath IF, Szodoray P, Zeher M (2008) Primary Sjogren’s syndrome in men: clinical and immunological characteristic based on a large cohort of Hungarian patients. Clin Rheumatol 27:1479–1483PubMedCrossRef
4.
go back to reference Ramos-Casals M, Garcia-Carrasco M, Cervera R, Gaya J, Halperin I, Ubieto I, Aymamí A, Morlà RM, Font J, Ingelmo M (2000) Thyroid disease in primary Sjogren’s syndrome. Study in a series of 160 patients. Medicine (Baltimore) 79:103–108CrossRef Ramos-Casals M, Garcia-Carrasco M, Cervera R, Gaya J, Halperin I, Ubieto I, Aymamí A, Morlà RM, Font J, Ingelmo M (2000) Thyroid disease in primary Sjogren’s syndrome. Study in a series of 160 patients. Medicine (Baltimore) 79:103–108CrossRef
5.
go back to reference Orgiazzi J (1999) The spectrum of autoimmune thyroid diseases (AITD). Ann Med Interne (Paris) 150:294–300 Orgiazzi J (1999) The spectrum of autoimmune thyroid diseases (AITD). Ann Med Interne (Paris) 150:294–300
6.
go back to reference Jara LJ, Navarro C, Brito-Zeron MP, Garcia-Carrasco M, Escarcega RO, Ramos-Casals M (2007) Thyroid disease in Sjogren’s syndrome. Clin Rheumatol 26:1601–1606PubMedCrossRef Jara LJ, Navarro C, Brito-Zeron MP, Garcia-Carrasco M, Escarcega RO, Ramos-Casals M (2007) Thyroid disease in Sjogren’s syndrome. Clin Rheumatol 26:1601–1606PubMedCrossRef
7.
go back to reference Appenzeller S, Pallone AT, Natalin RA, Costallat LT (2009) Prevalence of thyroid dysfunction in systemic lupus erythematosus. J Clin Rheumatol 15:117–119PubMedCrossRef Appenzeller S, Pallone AT, Natalin RA, Costallat LT (2009) Prevalence of thyroid dysfunction in systemic lupus erythematosus. J Clin Rheumatol 15:117–119PubMedCrossRef
8.
go back to reference Foster H, Stephenson A, Walker D, Cavanagh G, Kelly C, Griffiths I (1993) Linkage studies of HLA and primary Sjogren’s syndrome in multicase families. Arthr Rheum 36:473–484CrossRef Foster H, Stephenson A, Walker D, Cavanagh G, Kelly C, Griffiths I (1993) Linkage studies of HLA and primary Sjogren’s syndrome in multicase families. Arthr Rheum 36:473–484CrossRef
9.
go back to reference Tiemann M, Asbeck R, Wacker HH (1996) Clonal B-cell reaction in Sjogren’s disease and Hashimoto’s autoimmune thyroiditis. Pathologe 17:289–295PubMedCrossRef Tiemann M, Asbeck R, Wacker HH (1996) Clonal B-cell reaction in Sjogren’s disease and Hashimoto’s autoimmune thyroiditis. Pathologe 17:289–295PubMedCrossRef
10.
go back to reference Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, Daniels TE, Fox PC, Fox RI, Kassan SS, Pillemer SR, Talal N, Weisman MH, European Study Group on Classification Criteria for Sjögren’s Syndrome (2002) Classification criteria for Sjögren’s syndrome: a revised version of the European criteria proposed by the American-European consensus group. Ann Rheum Dis 61:554–558PubMedCrossRef Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, Daniels TE, Fox PC, Fox RI, Kassan SS, Pillemer SR, Talal N, Weisman MH, European Study Group on Classification Criteria for Sjögren’s Syndrome (2002) Classification criteria for Sjögren’s syndrome: a revised version of the European criteria proposed by the American-European consensus group. Ann Rheum Dis 61:554–558PubMedCrossRef
11.
go back to reference Preliminary criteria for the classification of systemic sclerosis (scleroderma) (1980) Subcommittee for scleroderma criteria of the American rheumatism association diagnostic and therapeutic criteria committee. Arthr Rheum 23:581–590CrossRef Preliminary criteria for the classification of systemic sclerosis (scleroderma) (1980) Subcommittee for scleroderma criteria of the American rheumatism association diagnostic and therapeutic criteria committee. Arthr Rheum 23:581–590CrossRef
12.
go back to reference Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luhtra HS, Medsger TA Jr, Mitchell DM, Neustadt DH, Pinals RS, Schaller JG, Sharp JT, Wilder RL, Hunder GG (1988) The American rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis. Arthr Rheum 31:315–324CrossRef Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luhtra HS, Medsger TA Jr, Mitchell DM, Neustadt DH, Pinals RS, Schaller JG, Sharp JT, Wilder RL, Hunder GG (1988) The American rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis. Arthr Rheum 31:315–324CrossRef
13.
go back to reference Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, Schaller JG, Talal N, Winchester RJ (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthr Rheum 25:1271–1277CrossRef Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, Schaller JG, Talal N, Winchester RJ (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthr Rheum 25:1271–1277CrossRef
14.
go back to reference Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R, Derksen RH, Groot PG, Koike T, Meroni PL, Reber G, Shoenfeld Y, Tincani A, Vlachoyiannopoulos PG, Krilis SA (2006) International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 4:295–306PubMedCrossRef Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R, Derksen RH, Groot PG, Koike T, Meroni PL, Reber G, Shoenfeld Y, Tincani A, Vlachoyiannopoulos PG, Krilis SA (2006) International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 4:295–306PubMedCrossRef
15.
go back to reference Higgins JPT, Green S (eds) (2005) Cochrane handbook for systematic reviews of interventions 4.2.5 [updated May 2005]; section 8. In: The Cochrane library, issue 3. Wiley, Chichester Higgins JPT, Green S (eds) (2005) Cochrane handbook for systematic reviews of interventions 4.2.5 [updated May 2005]; section 8. In: The Cochrane library, issue 3. Wiley, Chichester
16.
go back to reference Lazarus MN, Isenberg DA (2005) Development of additional autoimmune diseases in a population of patients with primary Sjogren’s syndrome. Ann Rheum Dis 64:1062–1064PubMedCrossRef Lazarus MN, Isenberg DA (2005) Development of additional autoimmune diseases in a population of patients with primary Sjogren’s syndrome. Ann Rheum Dis 64:1062–1064PubMedCrossRef
17.
go back to reference Caramaschi P, Biasi D, Volpe A, Carletto A, Cecchetto M, Bambara LM (2007) Coexistence of systemic sclerosis with other autoimmune diseases. Rheumatol Int 27:407–410PubMedCrossRef Caramaschi P, Biasi D, Volpe A, Carletto A, Cecchetto M, Bambara LM (2007) Coexistence of systemic sclerosis with other autoimmune diseases. Rheumatol Int 27:407–410PubMedCrossRef
18.
go back to reference Ioannidis JPA, Vassiliou VA, Moutsopoulos HM (2002) Long-term risk of mortality and lymphoproliferative disease and predictive classification of primary Sjogren’s syndrome. Arthr Rheum 46:741–747CrossRef Ioannidis JPA, Vassiliou VA, Moutsopoulos HM (2002) Long-term risk of mortality and lymphoproliferative disease and predictive classification of primary Sjogren’s syndrome. Arthr Rheum 46:741–747CrossRef
19.
go back to reference Ramos-Casals M, Brito-Zeron P, Yaque J, Akasbi M, Bautista R, Ruano M, Claver G, Gil V, Font J (2005) Hypocomplementaemia as an immunological marker of morbidity and mortality in patients with primary Sjogren’s syndrome. Rheumatology 44:89–94PubMedCrossRef Ramos-Casals M, Brito-Zeron P, Yaque J, Akasbi M, Bautista R, Ruano M, Claver G, Gil V, Font J (2005) Hypocomplementaemia as an immunological marker of morbidity and mortality in patients with primary Sjogren’s syndrome. Rheumatology 44:89–94PubMedCrossRef
20.
go back to reference Avouac J, Airò P, Dieude P, Caramaschi P, Tiev K, Diot E, Sibilia J, Cappelli S, Granel B, Vacca A, Wipff J, Meyer O, Kahan A, Matucci-Cerinic M, Allanore Y (2010) Associated autoimmune diseases in systemic sclerosis define a subset of patients with milder disease: results from 2 large cohorts of European Caucasian patients. J Rheumatol 37:608–614PubMedCrossRef Avouac J, Airò P, Dieude P, Caramaschi P, Tiev K, Diot E, Sibilia J, Cappelli S, Granel B, Vacca A, Wipff J, Meyer O, Kahan A, Matucci-Cerinic M, Allanore Y (2010) Associated autoimmune diseases in systemic sclerosis define a subset of patients with milder disease: results from 2 large cohorts of European Caucasian patients. J Rheumatol 37:608–614PubMedCrossRef
21.
go back to reference Punzi L, Ostuni PA, Betterle C, De Sandre P, Botsios C, Gambari PF (1996) Thyroid gland disorders in primary Sjögren’s syndrome. Rev Rhum 63:809–814 Punzi L, Ostuni PA, Betterle C, De Sandre P, Botsios C, Gambari PF (1996) Thyroid gland disorders in primary Sjögren’s syndrome. Rev Rhum 63:809–814
Metadata
Title
The co-occurrence of Hashimoto thyroiditis in primary Sjogren’s syndrome defines a subset of patients with milder clinical phenotype
Authors
Paola Caramaschi
Domenico Biasi
Cristian Caimmi
Cinzia Scambi
Sara Pieropan
Giovanni Barausse
Silvano Adami
Publication date
01-05-2013
Publisher
Springer-Verlag
Published in
Rheumatology International / Issue 5/2013
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-012-2570-6

Other articles of this Issue 5/2013

Rheumatology International 5/2013 Go to the issue